# Decision Memo: Vertigo relief app Full report: https://ideanavigatorai.com/ideas/vertigo-relief-app/ Recorded: Not recorded ## Decision - Team verdict: Park - Validation verdict: Research (56/100) - Confidence: 58% - Recommendation: Keep this parked until the team has evidence for the next validation step: Build a lightweight landing page plus a no-code guided-Epley walkthrough and run targeted ads to vertigo/BPPV search terms; measure email signups and the share who complete the maneuver flow. Validate B2B demand by pitching 10-15 ENT/audiology/physio clinics on recommending it for between-visit home care and counting how many agree to trial it with patients. ## Team rationale No team rationale recorded yet. ## Reviewers - No named reviewers recorded. ## Source anchors - Buyer: Adults (skewing female and older) suffering recurrent positional vertigo/BPPV, plus ENT clinics, audiologists, and vestibular physiotherapists who could recommend or white-label the app for between-visit home care. - Market: Consumer digital health for vestibular disorders, specifically BPPV and dizziness self-management, within the broader telerehabilitation and digital therapeutics space. - Problem: BPPV is the most common vestibular disorder, yet sufferers face long waits for ENT/vestibular specialists and struggle to perform repositioning maneuvers like the Epley correctly at home from static diagrams. Without guided head-positioning, episode tracking, and recurrence coaching, patients self-treat incorrectly, relapse (recurrence occurs in roughly half of cases), and miss daily activities. - Thesis: Vertigo relief app should be tested as a narrow first-win workflow for Adults (skewing female and older) suffering recurrent positional vertigo/BPPV, plus ENT clinics, audiologists, and vestibular physiotherapists who could recommend or white-label the app for between-visit home care.. - Source: https://pmc.ncbi.nlm.nih.gov/articles/PMC2117684/ - Source: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4606415/ - Source: https://www.hopkinsmedicine.org/health/treatment-tests-and-therapies/home-epley-maneuver - Source: https://www.ncbi.nlm.nih.gov/books/NBK470308/ - Source: https://growthmarketreports.com/report/digital-vestibular-rehabilitation-platforms-market ## Validation rubric Rubric version: INAV-VALIDATION-2026-06-04 ### Demand signal - 6/10 (24% weight) Demand looks thin because the report has 4 source-backed signal(s), an editorial confidence of 58/100, and a defined buyer in Consumer digital health for vestibular disorders, specifically BPPV and dizziness self-management, within the broader telerehabilitation and digital therapeutics space.. - BPPV is the most frequent vestibular disorder, with cumulative lifetime prevalence reported between 2.4% and 10%, higher in women (about 3.2% vs 1.6% in men) and rising with age, per population-based epidemiology studies indexed on NIH/PMC. - Target buyer: Adults (skewing female and older) suffering recurrent positional vertigo/BPPV, plus ENT clinics, audiologists, and vestibular physiotherapists who could recommend or white-label the app for between-visit home care. ### Problem severity - 6.3/10 (22% weight) Problem severity is thin when the buyer pain, customer value, and dream-outcome scores are combined. - BPPV is the most common vestibular disorder, yet sufferers face long waits for ENT/vestibular specialists and struggle to perform repositioning maneuvers like the Epley correctly at home from static diagrams. Without guided head-positioning, episode tracking, and recurrence coaching, patients self-treat incorrectly, relapse (recurrence occurs in roughly half of cases), and miss daily activities. - BPPV is the most frequent vestibular disorder, with cumulative lifetime prevalence reported between 2.4% and 10%, higher in women (about 3.2% vs 1.6% in men) and rising with age, per population-based epidemiology studies indexed on NIH/PMC. ### Willingness to pay - 5.5/10 (20% weight) Willingness to pay is weak; the model has a monetization hypothesis, but it must still be proven through paid pilots or explicit pricing objections. - Freemium consumer subscription (core maneuver guides free; advanced tracking, history export, and reminders behind a monthly/annual plan) plus a B2B clinic tier where ENT/audiology/physio practices license the app for patient home programs. - Build a lightweight landing page plus a no-code guided-Epley walkthrough and run targeted ads to vertigo/BPPV search terms; measure email signups and the share who complete the maneuver flow. Validate B2B demand by pitching 10-15 ENT/audiology/physio clinics on recommending it for between-visit home care and counting how many agree to trial it with patients. ### Competitive saturation - 3.9/10 (18% weight) Competitive room is reduced by 3 recorded alternative(s); the wedge must stay narrow and differentiated. - Recorded alternative: Vertigo BPPV Vestibular Coach - Competitive score rewards a narrow wedge, not absence of research. ### Feasibility - 6.2/10 (16% weight) Feasibility is thin for a moderate build if the MVP is limited to the first measurable workflow. - Build a lightweight landing page plus a no-code guided-Epley walkthrough and run targeted ads to vertigo/BPPV search terms; measure email signups and the share who complete the maneuver flow. Validate B2B demand by pitching 10-15 ENT/audiology/physio clinics on recommending it for between-visit home care and counting how many agree to trial it with patients. - Regulatory and medical-claims risk: positioning the app as treating or curing BPPV can trigger FDA software-as-a-medical-device scrutiny and liability; marketing must stay within wellness/educational claims and carry medical disclaimers. ## Market gap Underserved segments: - Adults (skewing female and older) suffering recurrent positional vertigo/BPPV, plus ENT clinics, audiologists, and vestibular physiotherapists who could recommend or white-label the app for between-visit home care. who still run the workflow in spreadsheets, generic docs, email, or chat threads. - Small teams in Consumer digital health for vestibular disorders, specifically BPPV and dizziness self-management, within the broader telerehabilitation and digital therapeutics space. that feel the pain weekly but are too narrow for broad incumbents. - New adopters who need guided proof before committing to a larger platform. Feature gaps: - A narrow workflow that reaches value without configuration-heavy onboarding. - A buyer-facing proof artifact that shows time saved, risk reduced, or communication improved. - A handoff path from manual concierge service to repeatable software. Differentiation levers: - Use specificity as the wedge: one buyer, one workflow, one measurable result. - Show proof earlier than broad competitors with before-and-after examples and small pilot data. - Keep implementation lighter than incumbent suites or generic AI assistants. ## Roast and risks Promising enough to test, not strong enough to build broadly. Blind spots: - Regulatory and medical-claims risk: positioning the app as treating or curing BPPV can trigger FDA software-as-a-medical-device scrutiny and liability; marketing must stay within wellness/educational claims and carry medical disclaimers. - A broad AI assistant can flatten differentiation unless the wedge is painfully specific. - The first release can become a generic dashboard if the job is not named tightly. Hard questions: - Who wakes up already trying to solve this? - What do they stop paying for or stop doing when this works? - What proof would make a skeptical buyer trust it in one screen? - What is the smallest paid version of this idea? ## Kill criteria - Fewer than five qualified buyers agree to discuss the workflow after targeted outreach. - No buyer can name a current cost in time, money, risk, or reputation. - The first demo does not produce a clear next step, paid pilot, or specific objection. ## Offer ladder - **Lead magnet (Free)**: Vertigo Relief App checklist Goal: Capture qualified leads and learn the buyer's exact language. Value: Helps Adults (skewing female and older) suffering recurrent positional vertigo/BPPV, plus ENT clinics, audiologists, and vestibular physiotherapists who could recommend or white-label the app for between-visit home care. audit the painful workflow before buying software. - **Frontend offer ($19-$99)**: Concierge review or paid template Goal: Validate urgency, workflow fit, and willingness to pay. Value: Delivers the first useful output manually before automation is trusted. - **Core offer ($49-$499/month)**: Vertigo relief app focused SaaS Goal: Create the recurring revenue product after the narrow wedge survives tests. Value: Turns the recurring manual workflow into a repeatable product loop. - **Continuity ($99-$1,000/year add-on)**: Monitoring, benchmarks, and monthly reporting Goal: Increase retention and make the product part of a routine. Value: Keeps the buyer engaged with ongoing proof, saved time, or reduced risk. - **Backend offer (Custom)**: Done-with-you setup, agency, or team rollout Goal: Capture higher-value accounts once the productized wedge is proven. Value: Adds implementation help, integrations, and workflow migration.